Proteomics and cardiovascular disease;Proteómica y enfermedad cardiovascular

Revista Espanola de Cardiologia

Volumn 56, Issue 3, 2003, Pages 289-302

  Vivanco, Fernando ^a,b   López Bescós, Lorenzo ^c   Tuñón, José ^d   Egido, Jesús ^d  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Cardiovascular diseases; Dilated cardiomyopathy; Genomics; Mass spectrometry; Proteins; Proteomics; Two dimensional electrophoresis

Indexed keywords

NEW DRUG; PROTEASOME; PROTEOME;

CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL COMPOSITION; CELL FUNCTION; CELL STIMULATION; CELL TYPE; CYTOSKELETON; DNA MICROARRAY; DRUG TARGETING; ENERGY YIELD; GENE EXPRESSION; GENOMICS; HEART MUSCLE CELL; HISTORY OF MEDICINE; HUMAN; HUMAN GENOME; MEDICAL INFORMATION; PATHOPHYSIOLOGY; PROTEIN PROCESSING; PROTEOMICS; REVIEW; STRESS; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 0038747989     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13043955     Document Type: Review

References (97)

1. Pandey A, Mann M. Proteomics to study genes and genomes. Nature 2000;405:837-46.
2. Williams KL. Genomes and Proteomes: towards a multidimensional view of biology. Electrophoresis 1999;20:678-88.
3. Naaby-Hansen S, Waterfield D, Cramer R. Proteomics: post-genomic cartography to understand gene function. Trends Pharm Sci 2001;22:376-85.
4. O'donovan C, Apweiler M, Bairoch A. The human proteomics initiative (HPI). Trends Biotechonol 2001;19:178-81.
5. Lee KH. Proteomics: a technology-driven and technology-limited discovery science. Trends Biotechnol 2001;19:217-22.
6. Collins F, Lander E. DNA microarrays. Nature Genetics 1999; 21(Suppl 1):1-56.
7. Blackstock W, Weir M. Proteomics: quantitative and physical mapping of cellular proteins. Tibtech 1999;17:121-7.
8. Liebler DC. Introduction to Proteomics. Tools for the new biology. Totowa: Humana Press NJ, 2002; p. 15-24.
9. Gygi SP. Correlation between protein and mRNA abundance in yeast. Moll Cell Biol 1999;19:1720-30.
10. Abbott A. A post-genomic challenge: learning to read patterns of protein synthesis. Nature 1999;402:715-20.
11. Lee RT. Fuctional genomics and cardiovascular drug discovery. Circulation 2001;104:1441-6.
12. Gygi S, Rist B, Aebersold R. Measuring gene expression by quantitative proteome analysis. Curr Opin Biotechnol 2000;11: 396-401.
13. Anderson N, Matheson A, Steiner S. Proteomics: applications in basic and applied biology. Curr Opin Biotechnol 2000;11:408-12.
14. Williams K, Hochstrasser F. Introduction to the Proteome. En: Wilkins MR, Williams K, Appel R, Hochstrasser D, editor. Proteome Research: New frontiers in Functional Genomics. Nueva York: Springer, 1997; p. 1-12.
15. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000;21:1037-53.
16. Washburn M, Yates J. New methods of proteome analysis: multi-dimensional chromatography and mass spectrometry. Proteomics: A Trend Guide 2000; 27-30.
17. Figeys D, Aebersold R. High sensitivity analysis of proteins and peptides by capillary electrophoresis-tandem mass spectrometry: recent developments in technology and applications. Electrophoresis 1998;19:885-92.
18. Mann M, Hendrickson R, Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem 2001; 70: 437-73.
19. Görg A. Advances in 2D gel techniques. Proteomics: A Trend Guide 2000; 3-6.
20. Klose J. Large-gel 2-D electrophoresis. Meth Mol Biol 1999; 112:147-72.
21. Stahl D, Lee T. Data controlled microscale liquid chromatography-tandem mass spectrometry of peptides and proteins: strategies for improved sensitivity, efficiency and effectiveness. En: James P, editor. Proteome Research: Mass spectrometry. Berlín: Springer, 2001; p. 55-73.
22. Spangler B. The basics of matrix-assisted laser desorption, ionisation time of flight mass spectrometry and post-source decay analysis. En: James P, editor. Proteome Research: Mass spectrometry. Berlín: Springer, 2001; p. 33-51.
23. Dainese P, James P. Protein identification by peptide mass finger-printing. En: James P, editor. Proteome Research: Mass spectrometry. Berlín: Springer, 2001; p. 103-21.
24. Jonssons AP. Mass spectrometry for protein and peptide characterization. Cell Mol Life Sci 2001;58:868-84.
25. Larsen M, Roepstorff P. Mass spectrometric identification of proteins and characterization of their post-translational modifications in proteome analysis. Anal Chem 2000;366:677-90.
26. Griffiths W, Jonson P, Liu S, Rai K, Wang Y. Electrospray and tandem mass spectrometry in biochemistry. Biochem J 2001;355: 545-61.
27. Kinter M, Sherman N. Protein sequencing and identification using tandem mass spectrometry. New York: Wiley Interscience, 2000.
28. Arrel K, Neverova I, Van Eyk J. Cardiovascular proteomics. Evolution and Potential. Circ Res 2001;88:763-73.
29. Macri J, Rapundalo ST. Application of proteomics to the study of cardiovascular biology. Trends Cardiovasc Med 2001;11:66-75.
30. Dunn M. Studying heart disease using the proteomic approach. Drug Discovery Today 2000;5:76-84.
31. Roberts R. Genética molecular de las miocardiopatías. Rev Esp Cardiol 2002;55:292-302.
32. Rojas Martínez A, Delgado Enciso Ro I. Genética y medicina molecular en cardiología. Rev Esp Cardiol 2001;54:91-108.
33. Moseley MA. Current trends in differential expression proteomics: isotopically coded tags. Trends Biotechnol 2001;19(Suppl): S10-S6.
34. Corbett JM, Wheeler CH, Dunn MJ. Coelectrophoresis of cardiac tissue from human, dog, rat and mouse. Towards the establishment of an integrated two-dimensional protein database. Electrophoresis 1995;16:1524-9.
35. Pleiâner KP, Sander S, Oswald H, Regitz-Zagrosek V, Fleck E. Towards design and comparison of World Wide Web accesible myocardial two-dimensional gel electrophoresis protein data bases. Electrophoresis 1997;18:1386-92.
36. Li XP, Pleissner K, Scheler C, Regitz-Zagrosek V, Salnikov J, Jungblut PR. A two-dimensional electrophoresis database of rat heart proteins. Electrophoresis 1999;20:891-7.
37. Evans G, Wheeler CH, Corbett JM, Dunn, MJ. Construction of HSC-2DPAGE: a two-dimensional gel electrophoresis database of heart proteins. Electrophoresis 1997;18:471-9.
38. Baker C S, Corbett MJ, May A, Yacoub M, Dunn M. A human myocardial two-dimensional electrophoresis database: protein characterisation by microsequencing and immunoblotting. Electrophoresis 1992;13:723-6.
39. Corbett JM, Wheeler C, Baker C, Yacoub M, Dunn M. The human myocardial two-dimensional gel protein database: update. Electrophoresis 1994;15:1459-65.
40. Jungblut P, Otto A, Zeindl-Eberhart E, Pleibner K, Knecht M, Regitz-Zagrosek V, et al. Protein composition of the human heart: the construction of a myocardial two-dimensional electrophoresis database. Electrophoresis 1994;15:685-707.
41. Müller E, Thiede B, Zimmy-Arndt U, Scheler C, Müller-Werdan U, Wittmann-Liebold B, et al. High-performance human myocardial two-dimensional electrophoresis database: edition 1996. Electrophoresis 1996;17:1700-12.
42. Pleibner K, Sander S, Oswald H, Regitz-Zagrosek V, Fleck E. The construction of the World Wide Web accesible myocardial two-dimensional gel electrophoresis protein database «Heart-2DPAGE»: a practical approach. Electrophoresis 1996;17:1386-92.
43. Pleibner K, Söding P, Sander S, Oswald H, Neub M, Regitz-Zagroseb V, et al. Dilated cardiomyopathy associated proteins and their presentation in a WWW accesible two-dimensional gel protein database. Electrophoresis 1997;18:802-8.
44. Jungblut P, Otto A, Regitz V, Fleck E, Wittmann-Liebold B. Identification of human myocard proteins separated by two-dimensional electrophoresis. Electrophoresis 1992;13:739-41.
45. Kovalayov L, Naumov V, Pulyayeva H, Samlo A, Tsvetkova M, Shishkin S, et al. Two-dimensional electrophoresis of heart muscle proteins in human cardiomyopathies. Electrophoresis 1990; 11:333-6.
46. Sutton C, Pemberton K, Cottrell J, Corbett J, Wheeler C, Dunn M, et al. Identification of myocardial proteins from two-dimensional gels by peptide mass fingerprinting. Electrophoresis 1995;16:308-16.
47. Lovalyov L, Shishkin S, Efimochkin S, Kovalyova M, Ershova E, Egorov T, et al. The major protein expression profile and two-dimensional protein database of human heart. Electrophoresis 1995;16:1160-9.
48. Pleibner K, Regitz-Zagroseb V, Weise C, Neub M, Krüdewagen B, Söding P, et al. Chamber-specific expression of human myocardial proteins detected by two-dimensional gel electrophoresis. Electrophoresis 1995;16:841-50.
49. Otto A, Thiede B, Müller E, Wittman-Liebold B, Jungblut P. Identification of human myocardial proteins by two-dimensional electrophoresis using an effective sample preparation for mass spectrometry. Electrophoresis 1996;17:1643-50.
50. Thiede B, Otto A, Zimmy-Arndt U, Müller E, Jungblut P. Identification of human myocardial proteins separated by two-dimensional electrophoresis with matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 1996;17: 588-99.
51. Jungblut P, Zimmy-Arndt U, Zeindi-Eberhart E, Stulik J, Koupilova K, Pleibner K. Proteomics in human disease: cancer, heart and infectious disease. Electrophoresis 1999;20:2100-10.
52. Heinke M, Wheeler C, Chang D, Einstein R, Drake-Holland A, Dunn M. Protein changes observed in pacing induced heart failure using two-dimensional electrophoresis. Electrophoresis 1998; 19:2021-30.
53. Scheler C, Müller E, Stahl J, Müller-Werdan U, Salnikow J, Jungblut P. Identification and characterization of heat shock protein 27 protein species in human myocardial two-dimensional electrophoresis patterns. Electrophoresis 1997;18:2823-31.
54. Scheler C, Li XP, Salnikov J, Dunn MJ, Jungblut PR. Comparison of two dimensional electrophoresis patterns of heat shock proteins Hsp27 species in normal and cardiomyopathic hearts. Electrophoresis 1999;20:3623-8.
55. Macri J, Dubay T, Mattesson D, Rapundalo ST. Characterization of the protein profile associated with endothelin-induced hypertrophy in neonatal rat myocytes. J Moll Cell Cardiol 2000;32:A60.
56. Macri J, McGee B, Thomas JN, Du P, Stevenson TI, Kilby G, et al. Cardiac sarcoplasmic reticulum and sarcolemmal proteins separated by two-dimensional electrophoresis: surfactant effects on membrane solubilization. Electrophoresis 2000;21:1116-693.
57. Patel V, Corbett JM, Dunn MJ, Winrow VR, Portmann B, Richardson P, et al. Protein profiling in cardiac tissue in response to the chronic effects of alcohol. Electrophoresis 1997;18:2788-94.
58. Sutton CW, Wheeler CH, Sally U, Corbett JM, Cottreell JS, Dunn MJ. The analysis of myocardial proteins by infrared and ultraviolet laser desorption mass spectrometry. Electrophoresis 1997;18:424-31.
59. Toraason M, Moorman W, Mathias PI, Fultz C, Witzmann F. Two-dimensional electrophoretic analysis of myocardial proteins from lead-exposed rabbits. Electrophoresis 1997;18:2978-82.
60. Heinke M, Wheeler C, Yan J, Amin V, Chang D, Einstein R, et al. Changes in myocardial protein expression in pacing-induced canine heart failure. Electrophoresis 1999;20:2086-93.
61. Corbett J, Why H, Wheeler C, Richardson P, Archad L, Yacoub M, et al. Cardiac protein abnormalities in dilated cardiomyopathies detected by two-dimensional polyacrylamide electrophoresis. Electrophoresis 1998;19:2031-42.
62. Knecht M, Regitz-Zagrosek V, Pleissner K, Jungblut P, Steffen C, Hildebrandt A, et al. Characterization of myocardial protein composition in dilated cardiomyopathy by two-dimensional gel electrophoresis. Eur Heart J 1994;15(Suppl):37-44.
63. Weekes J, Wheeler C, Yan J, Weil J, Eschenhagen T, Scholtysik G, et al. Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis 1999;20:898-906.
64. Wynne J, Braunwald E. The cardiomyopathies and myodarditides. En: Braunwald E, Zipes DP, Libby P, editors. Heart Disease. Philadelphia: Saunders, 2001; p. 1751-806.
65. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001;104:557-67.
66. Franco D, Dominguez J, De Castro MP, Aranega A. Regulación de la expresión génica en el miocardio durante el desarrollo cardíaco. Rev Esp Cardiol 2002;55:167-84.
67. Ruiz-Lozano P, Nakamura T, Chien KR. Genes del desarrollo, y enfermedad cardíaca. Rev Esp Cardiol 2002;55:1439-45.
68. Dalloz F, Osinka H, Robbins J. Modelos animales genéticamnte modificados en investigación cardiovascular. Rev Esp Cardiol 2001;54:764-89.
69. Field M, Clark J. Inappropriate ubiquitin conjugation: a proposed mechanism contributing to heart failure. Card Res 1997;33:8-12.
70. Ping P, Zhang J, Pierce WM, Bolli R. Functional Proteomic analysis of protein kinase C E signaling complexes in the normal heart and during cardioprotection. Circ Res 2001:88:59-62.
71. Arrell DK, Neverova I, Fraser H, Marban E, Van Eyk J. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ Res 2001;89:480-7.
72. Vondriska T, Klein J, Ping P. Use of functional proteomics to investigate PKCε-mediated cardioprotection: the signaling module hypothesis. Am J Physiol Heart Circ Physiol 2001;280:H1434-41.
73. Damer CK, Partridge J, Pearsson W, Haysstead T. Rapid identification of protein phosphatase 1 binding proteins by mixed peptide sequencing and data base searching. J Biol Chem 1998;273:24396-405.
74. Neverova I, Van Eyk JE. Application of reversed phase high performance liquid chromatography subproteomic analysis of cardiac muscle. Proteomics 2002;2:22-31.
75. Lopez M, Melov S. Applied Proteomics. Mitochondrial proteins and effect on function. Circ Res 2002;90:380-9.
76. Kernec F, Unlu M, Labeikovsky W, Minden J, Koretsky AP. Changes in the mitochondrial proteome from mouse hearts deficient in creatine kinase. Physiol Genomics 2001;17:117-28.
77. Berry DA, Keogh A, Dos Remedios CG. Nuclear membrane proteins in failing human dilated cardiomyopathy. Proteomics 2001;1:1507-12.
78. Martínez-González J, Llorente-Cortés V, Badimon L. Biología celular y molecular de las lesiones ateroscleróticas. Rev Esp Cardiol 2001;54:218-31.
79. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1,042 consecutive patients. Circulation 2002;105:1412-5.
80. Agrafiotis D, Lobanov V, Salemme R. Combinatorial informatics in the post-genomic era. Nature Reviews. Drug Discovery 2002;1:337-46.
81. Tongue R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J, et al. Validation and development of fluorescence two-dimensional differential electrophoresis proteomics technology. Proteomics 2001;1:377-96.
82. Gygi S, Rist B, Gerber S, Turecek F, Gelb M, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotech 1999;17:994-9.
83. Smolka M, Zhou H, Purkayastha S, Aebersold R. Optimization of the isotope coded affinity tag labeling procedure for quantitative proteome analysis. Anal Biochem 2001;297:25-31.
84. Speicher D. Proteomics: an infinite problem with infinite potential. The Scientist 2002;16:12-4.
85. Hwang D, Dempsey A, Lee C, Liew C. Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics 2000;66:1-14.
86. Shimkes R, Lowe D, Tai J, Sehl P, Jin H, Murtha M, et al. Gene expression analysis by transcript profiling coupled to a gene database query. Nature Biotech 1999;17:798-803.
87. Hoshijima M, Chien K. Mixed signals in heart failure: cancer rules. J Clin Invest 2002;109:849-55.
88. Rubin E, Tall A. Perspectives for vascular genomics. Nature 2000;407:265-9.
89. Chien K. Genomics circuits and the integrative biology of cardiac diseases. Nature 2000;407:227-32.
90. Jin H, Yang R, Awad T, Wang F, Williams S, De Feo G, et al. Effects of early angiotensin converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation 2001;103:736-42.
91. Sehl P, Tai J, Hillan K, Brown L, Goddard A, Yang R, et al. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development and response to injury. Circulation 2000;101:1990-9.
92. Yang J, Moravec C, Sussman M, DiPaola N, Fu D, Mitchell C, et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 2000;102:3046-52.
93. Stanton L, Garrad L, Damm D, Garrick B, Lam A, Kapoun A, et al. Altered patterns of gene espression in response to myocardial infarction. Circ Res 2000;86:939-45.
94. Friddle C, Koga T, Rubin E, Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci 2000;97:6745-50.
95. Faber B, Cleutjens K, Niessen R, Aarts P, Boon W, Greenberg A, et al. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res 2001;89:547-54.
96. Hwang JJ, Dzau V, Liew CC. Genomics and the pathophysiology of heart failure. Curr Cardiol Rep 2001;3:198-207.
97. Jiang L, Tsubakihara M, Heinke M, Yao M, Dunn M, Phillips W, et al. Heart failure and apoptosis: electrophoretic methods support data from micro- and macro-arrays. A critical review of genomics and proteomics. Proteomics 2001;1:1481-8.